Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy

Bibliographic Details
Main Author: Tian Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1081912/full
_version_ 1811211000743985152
author Tian Tian
author_facet Tian Tian
author_sort Tian Tian
collection DOAJ
first_indexed 2024-04-12T05:05:32Z
format Article
id doaj.art-fe57f59dfea14e27900b09357f5508b0
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-12T05:05:32Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-fe57f59dfea14e27900b09357f5508b02022-12-22T03:46:53ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-11-011310.3389/fphar.2022.10819121081912Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapyTian Tianhttps://www.frontiersin.org/articles/10.3389/fphar.2022.1081912/fullbreast cancercell deathapoptosischemoresisitanceexon deletion
spellingShingle Tian Tian
Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
Frontiers in Pharmacology
breast cancer
cell death
apoptosis
chemoresisitance
exon deletion
title Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
title_full Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
title_fullStr Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
title_full_unstemmed Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
title_short Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
title_sort commentary a gsh cb dual controlled self assembled nanomedicine for high efficacy doxorubicin resistant breast cancer therapy
topic breast cancer
cell death
apoptosis
chemoresisitance
exon deletion
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1081912/full
work_keys_str_mv AT tiantian commentaryagshcbdualcontrolledselfassemblednanomedicineforhighefficacydoxorubicinresistantbreastcancertherapy